COEP·19207A207·US·equity·Healthcare - Biotechnology-Activist
COEP (COEPTIS THERAPEUTICS HLDGS I) is held by 9 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($596,124), STATE STREET CORP ($301,033), UNITED CAPITAL FINANCIAL ADVISORS, LLC ($224,400). Net institutional sentiment: Mixed.
See how COEP's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer